SCHEMBL24244944

SCHEMBL24244944

CCOC(=O)c1ccc(N2CCN(C(C)=O)CC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 10/20 0.58
LMNA P02545 3/20 0.58
KDM4E B2RXH2 2/20 0.58
GAA P10253 2/20 0.58
GFER P55789 2/20 0.56
CASP6 P55212 1/20 0.56
HPGD P15428 4/20 0.55
HTT P42858 4/20 0.55
ALDH1A1 P00352 10/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
SYK P43405 1/20 0.54
KMT2A Q03164 4/20 0.53
MEN1 O00255 3/20 0.53
TSHR P16473 3/20 0.53
HSP90AA1 P07900 2/20 0.53
TDP1 Q9NUW8 2/20 0.53
MAPK1 P28482 2/20 0.53
HSP90AB1 P08238 1/20 0.53
ALOX15 P16050 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20188098 0.91 HPGD (0.65) MAPTLMNAKDM4EGAAHPGD
SCHEMBL22015905 0.91 HPGD (0.65) MAPTLMNAKDM4EGAAHPGD
SCHEMBL8703730 0.90 MAPT (0.73) MAPTLMNAKDM4EGAAHPGD
SCHEMBL2723301 0.88 MAPT (0.58) MAPTLMNAKDM4EGAAHPGD
SCHEMBL10770347 0.87 HPGD (0.56) MAPTLMNAKDM4EGAAHPGD
SCHEMBL20187714 0.86 HPGD (0.59) MAPTLMNAKDM4EGAAHPGD
SCHEMBL3067260 0.85 ALDH1A1 (0.58) MAPTLMNAKDM4EGAAHPGD
SCHEMBL5324137 0.85 CYP2C9 (0.62) MAPTLMNAKDM4EGAAHPGD
SCHEMBL3898465 0.84 HPGD (0.61) MAPTLMNAGAAHPGDHTT
SCHEMBL28242074 0.84 HPGD (0.61) MAPTLMNAKDM4EGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220041559-A1 BENZO-AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS ROTTAPHARM BIOTECH S.R.L. (IT) 2022-02-10 US disclosed
CN-114008026-A Benzopyrazoles and pyridopyrazoles as protein kinase inhibitors 罗达制药生物技术有限责任公司 2022-02-01 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220041559-A1 BENZO-AND PYRIDO-PYRAZOLES AS PROTEIN KINASE INHIBITORS PDXK, MAP4K2, PLK2 MAPT 578/4885LMNA 2616/4885KDM4E 1169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.